Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase II/III Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination with Umbralisib and Venetoclax U2-V Compared to Ublituximab and Umbralisib U2 in Subjects with Chronic Lymphocytic Leukemia CLL
Study Type: Treatment
Phase: II
NCTID: NCT03801525
Principal Investigator:
Marc Hoffmann
A Multi-Center, Open Label Study to Assess the Safety, Steady-State Pharmacokinetics and Pharmacodynamics of IMG-7289 in Patients with Myelofibrosis
A Window of Opportunity Study to Characterize the Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics of CPX-POM in Patients with Newly Diagnosed or Recurrent Bladder Tumors
Phase I study of epacadostat INCB24360 in combination with sirolimus in advanced malignancy
A Phase IB/II, Open-Label, Multicenter, Randomized, Controlled Study Investigating the Safety, Tolerability, Pharmacokinetics, And Efficacy of Mosunetuzumab BTCT4465a In Combination with Chop or CHP-Polatuzumab Vedotin In Patients With B-Cell Non-Hodgkin Lymphoma
Study Type: Treatment
Phase: I/II
NCTID: NCT03677141
Principal Investigator:
Marc Hoffmann
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer COMPPARE
Study used for generating invoices to post general sponsor payment not specific to one study but to our KUCC site as a whole or to a group of studies
Study Type:
Phase:
NCTID:
Principal Investigator:
A Phase Ib/IIa Trial Of CEND?1 In Combination With Neoadjuvant FOLFIRINOX Based Therapies In Pancreatic, Colon And Appendiceal Cancers CENDIFOX
Study Type: Treatment
Phase: I/II
NCTID: NCT05121038
Principal Investigator:
Anup Kasi